首页> 外文期刊>Gastrointestinal Endoscopy >A combination of clinical risk stratification and fecal immunochemical test results to prioritize colonoscopy screening in asymptomatic participants
【24h】

A combination of clinical risk stratification and fecal immunochemical test results to prioritize colonoscopy screening in asymptomatic participants

机译:结合临床风险分层和粪便免疫化学测试结果,优先对无症状参与者进行结肠镜检查

获取原文
获取原文并翻译 | 示例
           

摘要

Stool-based colonoscopy is the preferred strategy for colorectal cancer (CRC) screening. The Asia-Pacific Colorectal Screening System (APCS) score also is helpful in stratifying the risk for advanced neoplasia in the asymptomatic population. The combination of the fecal immunochemical test (FIT) result and clinical risk stratification may be more helpful in stratifying the risk.
机译:基于凳子的结肠镜检查是结直肠癌(CRC)筛查的首选策略。亚太大肠癌筛查系统(APCS)评分也有助于对无症状人群进行晚期肿瘤形成的风险进行分层。粪便免疫化学测试(FIT)结果与临床风险分层相结合可能更有助于将风险分层。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号